MedPath

Indwelling Interscalene Nerve Catheters in Surgical Management of Idiopathic Adhesive Capsulitis

Not Applicable
Conditions
Frozen Shoulder
Interventions
Procedure: Interscalene block with nerve catheter
Registration Number
NCT01606332
Lead Sponsor
OAD Orthopaedics
Brief Summary

In patients who undergo shoulder manipulation for idiopathic adhesive capsulitis, a postoperative indwelling analgesic pain catheter will improve patient outcomes by decreasing shoulder pain and improving range of motion compared to a single-dose interscalene block.

Detailed Description

Shoulder manipulation under anesthesia to treat idiopathic adhesive capsulitis is performed only when conservative treatment fails to remedy the condition.

It is common practice to use an interscalene nerve block as anesthesia for this surgical intervention. This randomized prospective study is designed to evaluate the effects of two different anesthesia methods on patient's post-surgical rehabilitation after manipulation. Forty patients scheduled for surgery will be entered into this study. Patients will be randomly assigned to receive a single-doseinterscalene block or a single-dose interscalene block and an indwelling nerve catheter which will provide a continuous infusion of local anesthetic. Patients with the continuous infusion of local anesthetic will receive the additional anesthesia for 24 hours. Patient's range of motion will be evaluated pre-op, intra-op and post-operatively at 10 days, 4,8,16 weeks and 6 months

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Males and Females over the age of 18 with a diagnosis of idiopathic adhesive capsulitis
  • Failed conservative treatment for a minimum of 4 months
  • Patient had 3 sequential office visits with no clinical improvement
Exclusion Criteria
  • Adhesive capsulitis following a surgical procedure and/or fracture

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Interscalene block with nerve catheterInterscalene block with nerve catheterInterscalene block with ropivacaine 0.5% 10ml and placement of an indwelling nerve catheter with ropivacaine 0.2% @5ml/hr for 24 hours
Primary Outcome Measures
NameTimeMethod
Improvement in shoulder function as demonstrated by increased range of motion10 days, 4, 8, 16 weeks and 6 months

The primary outcome measure will be an improvement in shoulder function as measured by the ASES shoulder score.

Secondary Outcome Measures
NameTimeMethod
Decrease in shoulder pain10 days, 4, 8, 16 weeks and 6 months

The secondary outcome measure will be a reduction in shoulder pain as measured by the VAS pain score.

Trial Locations

Locations (1)

OAD Orthopaedics

🇺🇸

Warrenville, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath